MG therapy combinations at last follow-up.
| MG therapy | Number (%) |
|---|---|
| Prednisolone and azathioprine | 28 (29.5) |
| Prednisolone alone | 19 (20.0) |
| Prednisolone and Mycophenolate | 10 (10.5) |
| Pyridostigmine alone | 8 (8.4) |
| Prednisolone, azathioprine and IVIg | 7 (7.4) |
| Azathioprine alone | 4 (4.2) |
| Prednisolone and Rituximab | 3 (3.2) |
| Prednisolone, azathioprine, IVIg and Rituximab | 3 (3.2) |
| Prednisolone, azathioprine and Rituximab | 2 (2.1) |
| Prednisolone, Mycophenolate, IVIg, and Rituximab | 2 (2.1) |
| Prednisolone, Rituximab, and IVIg | 1 (1.1) |
| Prednisolone, Mycophenolate, and IVIg | 1(1.1) |
| Azathioprine, Mycophenolate, and IVIg | 1 (1.1) |
| Prednisolone and IVIg | 1 (1.1) |
| No current therapy | 5 (5.3) |
| ≥ 2 immunosuppressive therapies | 58 (61.1) |
MG - myasthenia gravis, IVIg - intravenous immunoglobulin